Patients with early-stage breast cancer who had a pathologic complete response (pCR) to neoadjuvant chemotherapy may be able to skip surgery and receive standard radiation treatment with a low chance of disease recurrence, according to a new study.
from Women's Health News -- ScienceDaily https://ift.tt/ipS4xRC
Wednesday, October 26, 2022
Tuesday, October 25, 2022
Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer
Researchers have developed a drug that so specifically targets a deadly kind of breast cancer that there are little to no toxic side effects. Next, it will be tested in phase 1 clinical trials in humans.
from Women's Health News -- ScienceDaily https://ift.tt/phSwts9
from Women's Health News -- ScienceDaily https://ift.tt/phSwts9
Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer
Researchers have developed a drug that so specifically targets a deadly kind of breast cancer that there are little to no toxic side effects. Next, it will be tested in phase 1 clinical trials in humans.
from Women's Health News -- ScienceDaily https://ift.tt/phSwts9
from Women's Health News -- ScienceDaily https://ift.tt/phSwts9
Scientists pinpoint druggable target in aggressive breast cancer
Researchers have set their sights on a new therapeutic target for an aggressive form of breast cancer with limited treatment options. Through a comprehensive and cutting-edge genomic screening method known as CRISPR/CAS9 screening, scientists were able to identify a specific enzyme called UBA1 that revealed itself as an ideal therapeutic target. Using a novel UBA-inhibiting drug called TAK-243, they blocked the cellular function of UBA1 and effectively killed cancer cells in patient-derived breast tumors in mice.
from Women's Health News -- ScienceDaily https://ift.tt/mdChF7e
from Women's Health News -- ScienceDaily https://ift.tt/mdChF7e
How intermittent fasting affects female hormones
Intermittent fasting has been shown to be an effective way to lose weight, but critics have worried that the practice may have a negative impact on women's reproductive hormones. Now, a team brings new evidence to the table.
from Women's Health News -- ScienceDaily https://ift.tt/Oz9x3AJ
from Women's Health News -- ScienceDaily https://ift.tt/Oz9x3AJ
How intermittent fasting affects female hormones
Intermittent fasting has been shown to be an effective way to lose weight, but critics have worried that the practice may have a negative impact on women's reproductive hormones. Now, a team brings new evidence to the table.
from Women's Health News -- ScienceDaily https://ift.tt/a3ItfE6
from Women's Health News -- ScienceDaily https://ift.tt/a3ItfE6
Friday, October 21, 2022
Earlier mammograms for women with family history of breast cancer may not be needed
A new study may prompt medical experts to rethink when to start mammograms for women who have a mother, sister or daughter diagnosed with breast cancer.
from Breast Cancer News -- ScienceDaily https://ift.tt/D7nc31q
from Breast Cancer News -- ScienceDaily https://ift.tt/D7nc31q
Earlier mammograms for women with family history of breast cancer may not be needed
A new study may prompt medical experts to rethink when to start mammograms for women who have a mother, sister or daughter diagnosed with breast cancer.
from Women's Health News -- ScienceDaily https://ift.tt/D7nc31q
from Women's Health News -- ScienceDaily https://ift.tt/D7nc31q
Earlier mammograms for women with family history of breast cancer may not be needed
A new study may prompt medical experts to rethink when to start mammograms for women who have a mother, sister or daughter diagnosed with breast cancer.
from Women's Health News -- ScienceDaily https://ift.tt/D7nc31q
from Women's Health News -- ScienceDaily https://ift.tt/D7nc31q
Wednesday, October 19, 2022
Study sheds light on understudied breast cancer type
A multi-center analysis of patients with invasive lobular carcinoma, or ILC -- the second most common histological subtype of invasive breast cancer in the U.S. -- showed that, despite its prevalence, ILC is detected later and has worse outcomes than the predominant subtype of invasive breast cancer, known as invasive ductal carcinoma (IDC), or no special type.
from Women's Health News -- ScienceDaily https://ift.tt/oLYsp0y
from Women's Health News -- ScienceDaily https://ift.tt/oLYsp0y
Subscribe to:
Posts (Atom)